http://sify.com/news/blood-vessels-made-from-stem-cells-to-replace-synthetic-vascular-bypass-grafts-news-scitech-kejmEcegeie.html
By using adult stem cells, scientists have created functional blood vessels that could one day
replace synthetic grafts often required in various vascular bypass surgeries, new research has
revealed.
Bypass surgery is used to open blocked arteries in one part of the body by using a vessel from
elsewhere in the body. However, up to 40 percent of patients don't have a vessel suitable for the
procedure.
In such cases, surgeons use synthetic grafts, but the artificial blood vessels often become clogged
within one to three years at a higher rate than natural arteries often leading to serious
infections.
"Our grafts have the potential to be used for peripheral artery disease bypass (mostly in the
legs), and arteriovenous fistula (a type of vascular access for hemodialysis), and heart bypass
surgery. However, the first uses of the grafts would be for treatment of peripheral artery disease
and dialysis access grafting," said Dr. Stephen E. McIlhenny, lead author of the study and
tissue engineer of Thomas Jefferson University Hospital in Philadelphia.
The researchers came out with encouraging results from their first pre-clinical tests of the
graphs.
"It was our idea to create a more biological conduit that would avoid the problems of
synthetic grafts and give patients a better alternative. The significant finding is that we can
build a blood vessel from donor tissue and an animal's own adult stem cells. Potentially, patients
requiring bypass surgery could receive optimized grafts that would reduce their future
complications," said McIlhenny.
They grew rabbit adult stem cells on human vein scaffolds in the laboratory. The team removed all
cells from sections of human saphenous veins, which left a tube consisting only of the protein
scaffolding that supported the cells.
As the scaffolding contains no cells, there is less risk the immune system will reject it.
The researchers derived adult stem cells from the fat cells of each rabbit that would receive the
test graft.
They grew the stem cells on pieces of scaffolding, and each rabbit received a graft with only its
own stem cells on it.
"Fat cells are easily obtained with liposuction. Bone-marrow-derived stem cells require going
into the bone canal to take bone marrow out, which can be painful," said McIlhenny.
Surgeons cut the abdominal aorta of five male rabbits and inserted stem cell grafts into the large
artery. In five other male rabbits, they similarly inserted grafts of the bare protein scaffolding.
After eight weeks, surgeons removed the grafts from the 10 animals. The five bare scaffolding
grafts showed significant thickening akin to that seen in human cardiovascular disease, as well as
evidence of blood clots.
As for the other five grafts, "we found that using the stem cells as a coating prevented
clotting and thickening of the graft wall. I would say those grafts were significantly better,"
said McIlhenny.
The study was presented at the American Heart Association's Arteriosclerosis, Thrombosis and
Vascular Biology Annual Conference 2010.
Apr 9, 2010 (City)